CAS 168650-46-2 [Asp371]-Tyrosinase(369-377),human

Send Inquiry
CAS 168650-46-2 [Asp371]-Tyrosinase(369-377),human
Details
Human tyrosinase residues 369-377 with Asp at position 371;
Category: Engineered tumor epitope / melanoma CTL peptide.
Peptide Purity (HPLC) ≥95%
CAS No. 168650-46-2
Structure Linear variant epitope (human tyrosinase 369-377, Asp371)
Solubility DMSO/water cosolvent, PBS
Storage Powder, −20°C, dry, light-protected
Category
Epitope Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 168650-46-2 [asp371]-tyrosinase(369-377),human in China, also supports custom service. Welcome to wholesale bulk high quality cas 168650-46-2 [asp371]-tyrosinase(369-377),human from our factory. Contact us for more details.

 

Description Human tyrosinase 369–377 with position 371 replaced by Asp, used to probe how key residues affect MHC/TCR binding and immunogenicity; used for melanoma structure-activity studies.

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
[Asp371]-Tyrosinase (369-377) human (YMDGTMSQV, HLA-A*0201) YMDGTMSQV; CAS 168650-46-2; [Asp371]-human tyrosinase 369-377 peptide; Tyr369(D) deamidated epitope Tumor immunology, Melanoma, Post-translationally modified epitope, MHC-I antigen processing, Autoimmunity/vitiligo, HLA-A*0201 H-Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val-OH. Residues 369-377 of human tyrosinase (TYR, P14679); the naturally presented form in which Asn371 is post-translationally deamidated to Asp by PNGase deglycosylation (genomic sequence YMNGTMSQV); contains 2 Met + 1 Tyr; light-protected oxidation control. C42H66N10O16S2 1030.41 1031.16 Salt form vendor-dependent (Howei acetate / Ruixi TFA); confirm on order / per COA 9

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-TYR369-01 Off-white powder (>=95% purity) Store at -20°C, dry, sealed, light-protected; 2 Met + Tyr - keep light-protected, deaerated, avoid oxidants. Short-term storage at 2-8°C, dry and light-protected; avoid repeated freeze-thaw. Prepare fresh; soluble in aqueous buffer; small fraction of DMSO if needed; store stock in aliquots at -20°C, light-protected. powder stable for 2-3 years at -20°C, sealed and light-protected.

 

Functional Description

 

Product Code Frontend Short Summary Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-TYR369-01 HLA-A*0201 melanoma antigen peptide from human tyrosinase 369-377 (Asn371 deamidated to Asp), a 9-mer. HLA-A*0201-restricted melanoma tumor-antigen peptide generated by post-translational deamidation of Asn371 to Asp (PNGase-mediated deglycosylation) within human tyrosinase residues 369-377; recognized by autologous CTL and a classic model of retrotranslocation/deglycosylation-dependent MHC-I processing. Tumor immunology, Melanoma, Post-translationally modified epitope, MHC-I antigen processing, Autoimmunity/vitiligo Presented on HLA-A*0201 to CD8+ T cells; recognized on human tyrosinase-expressing melanoma cells.

 

 

 

 

Hot Tags: cas 168650-46-2 [asp371]-tyrosinase(369-377),human, China cas 168650-46-2 [asp371]-tyrosinase(369-377),human manufacturers, suppliers, factory, 125366-42-9, Ac MBP 1 11 , BCMA72-80, CAS 124454 83 7, CAS 2293841 58 2, CEF4

Send Inquiry